Matrigel® invasion by the prostate cancer cell lines, PC3 and DU145, and cathepsin L+B activity

Biotechnic and Histochemistry

Volumn 79, Issue 3-4, 2004, Pages 121-127

  Colella, Rita ^a   Jackson, T ^a   Goodwyn, E ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cathepsins L and B; DU145; E 64; Matrigel invasion assay; PC3; Phorbol ester PMA; Prostate cancer

Indexed keywords

CATHEPSIN B; CATHEPSIN L; CYSTEINE PROTEINASE INHIBITOR; MATRIGEL; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER DERIVATIVE; PROTEIN KINASE C; TUMOR PROMOTER; CATHEPSIN; COLLAGEN; CYSTEINE PROTEINASE; LAMININ; PROTEOGLYCAN;

ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; EXPOSURE; HUMAN; HUMAN CELL; METASTASIS; PHENOTYPE; PROSTATE CANCER; CANCER STAGING; CELL COUNT; CELL MOTION; CELL PROLIFERATION; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; MALE; METABOLISM; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

CATHEPSIN B; CATHEPSINS; CELL COUNT; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; CYSTEINE ENDOPEPTIDASES; DRUG COMBINATIONS; HUMANS; LAMININ; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSTATIC NEOPLASMS; PROTEOGLYCANS; TETRADECANOYLPHORBOL ACETATE;

EID: 11144260363     PISSN: 10520295     EISSN: None     Source Type: Journal    
DOI: 10.1080/10520290400010572     Document Type: Article

References (40)

1. Atkins KB, Troen BR (1995) Phorbol ester stimulated cathepsin L expression in U937 cells. Cell Growth Differen. 6: 713-718.
2. Atsma DE, Bastiaanse EM, Jerzewski A, Van der Valk LJ, Van der Laarse A (1995) Role of calcium-activated neutral protease (calpain) in cell death in cultured neonatal rat cardiomyocytes during metabolic inhibition. Circ. Res. 76: 1071-1078.
3. Azuma M, David LL, Shearer TR (1992) Superior prevention of calcium ionophore cataract by E64d. Biochim. Biophys. Acta 1180: 215-220.
4. Barrett AJ, Kirschke H (1981) Cathepsin B, cathepsin H and cathepsin L. Methods Enzymol. 80: 535-561.
5. Barrett AJ, Kembhavi AA, Brown MA, Kirschke H, Knight CG, Tamai M, Hanada K (1982) L-trans epoxysuccinyl-leucylamido-(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem. J. 201: 189-198.
6. Berquin IM, Yan S, Katiyar K, Huang L, Sloane BF, Troen BR (1999) Differentiating agents regulate cathepsin B gene expression in HL-60 cells. J. Leukocyte Biol. 66: 609-616.
7. Colella R, Goodwyn E, Gopal P (2002) Increased cell density decreases cysteine proteinase inhibitor activity and increases invasive ability of two prostate tumor cell lines. Cancer Lett. 185: 63-172.
8. Coulibaly S, Schwihla H, Abrahamson M, Albini A, Cerni C, Clark JL, Hg KM, Katunuma N, Schlappack O, Glossl J, Mach L (1999) Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int. J. Cancer 83: 526-531.
9. Dennhofer R, Kurschat P, Zingrino P, Klose A, Bosserhoff A, van Muyen G, Krieg T, Mauch C, Hunzelmann N (2003) Invasion of melanoma cells into dermal connective tissue in vitro: evidence for an important role of cysteine proteases. Int. J. Cancer 106: 316-323.
10. Fernandez PL, Farre X, Nadal A, Fernandez E, Peiro N, Sloane BF, Shi G-P, Chapman HA, Campo E, Cardesa A (2001) Expression of cathepsins B and S in the progression of prostate carcinoma. Int. J. Cancer 95: 51-55.
11. Friedrich B, Jung K, Lein M, Turk I, Rudolph B, Hampel G, Schnorr D, Loening SA (1999) Cathepsins B, H, L and cysteine proteinase inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue. Eur. J. Cancer 35: 138-144.
12. Gomez ED, Skilton G, Alonso DF, Kazanietz MG (1999) The role of protein kinase C and novel phorbol ester receptors in tumor cell invasion and metastasis (review). Oncol. Rep. 6: 1363-1370.
13. Guinec N, Dalet-Fumeron V, Pagano M (1993)"In vitro" study of basement membrane degradation by the cysteine proteinases, cathepsins B, B-like, and L. Biol. Chem. Hoppe-Seyler 374: 1135-1146.
14. Guo M, Mathieu PA, Linebaugh B, Sloane BF, Reiners JJ (2002) Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-β: A process initiated by the exocytosis of cathepsin B. J. Biol. Chem. 277: 14829-14837.
15. Heidtmann H-H, Salge U, Havemann K, Kirschke H, Wiederanders B (1993) Secretion of a latent, acid activatable cathepsin L precursor by human non-small-cell lung cancer cell lines. Oncol. Res. 5: 441-451.
16. Honn KV, Timar J, Rozhin J, Bazaz R, Sameni M, Ziegler G, Sloane BF (1994) A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells. Exp. Cell Res. 21114: 120-130.
17. Isakov N, Gopas J, Priel E, Segal S, Altman A (1991) Effect of protein kinase C activating tumor promoters on metastasis formation by fibrosarcoma cells. Invasion Metastasis 11: 14-24.
18. Johnson MD, Torri JA, Lippman ME, Dickson RB (1999) Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness. Exp. Cell Res. 247: 105-113.
19. Krueger S, Kellner U, Buehling F, Roessner A (2001) Cathepsin L antisense oligotutcleotides in a human osteosarcoma cell line: effects on the invasive phenotype. Cancer Gene Ther. 8: 522-528.
20. Levicar N, Dewey RA, Daley E, Bates TE, Davies D, Kos J, Pilkington GJ, Lah TT (2003) Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis. Cancer Gene Ther. 10: 141-151.
21. Liu B, Maher RJ, Hannun YA, Porter AT, Honn KV (1994) 12(S)-HETE enhancement of prostate tumor cell invasion: Selective role of PKC-α. J. Natl. Cancer Inst. 86: 1145-1151.
22. Lowry OH, Rosbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275.
23. Mignatti P, Robbins E, Rifkin DB (1986) Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade. Cell 47: 487-498.
24. O'Brian C (1998) Protein kinase C-α: A novel target for the therapy of androgen-independent prostate cancer? (Review-hypothesis). Oncol. Rep. 5: 305-309.
25. O'Brian C, Ward NE (1989) Biology of the protein kinase C family. Cancer Metast. Rev. 8: 199-214.
26. Popp O, Heidinger M, Ruiz-Heinrich L, Ries C, Jochum M, Gil-Parrado S (2003) The calpastatin-derived calpain inhibitor CP1B reduces mRNA expression of matrix metalloproteinase-2 and -9 and invasion by leukemic THP-1 cells. Biol. Chem. 384: 951-958.
27. Premzl A, Puizdar V, Zavasnik-Bergant V, Kopitar-Jerala N, Lah TT, Katunuma N, Sloane BF, Turk V, Kos J (2001) Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases. Biol. Chem. 382: 853-857.
28. Saleh Y, Siewinski M, Kielan W, Ziolkowski P, Grybos M, Rybka J (2003) Regulation of cathepsin B and L expression in vitro in gastric cancer tissues by egg cystatin. J. Exp. Therapeutics Oncol. 3: 319-324.
29. Schuermann M, Jager R, Salge U, Risse-Hackl G, Havemann K, Heidtmann H-H (1997) Control of proteinase expression by phorbol-ester- and fos-dependent pathways in human non-small-cell lung cancer cells. Int. J. Cancer 71: 275-283.
30. Siewinski M, Saleh Y, Popiela A, Ziolkowski P, Jelen M, Grybos M (2003) Expression of high molecular weight cysteine proteinase inhibitor in ovarian cancer tissues: regulation of cathepsin B expression by placental CPI. Biol. Chem. 384: 1103-1107.
31. Sinha AA, Gleason DF, Deleon OF, Wilson MJ, Sloane BF (1993) Localization of a biotinylated cathepsin B oligonucleotide probe in human prostate including invasive cells and invasive edges by in situ hybridization. Anat. Rec. 235: 233-240.
32. Sinha AA, Wilson MJ, Gleason DF, Reddy PK, Sameni M, Sloane BF (1995) Immunohistochemical localization of cathepsin B in neoplastic human prostate. Prostate 26: 171-178.
33. Sinha AA, Jamuar MP, Wilson MJ, Rozhin J, Sloane BF (2001) Plasma membrane association of cathepsin B in human prostate cancer: biochemical and immunogold electron microscope analysis. Prostate 49: 172-184.
34. Soderstrom K-O, Laato M, Wu P, Hopsu-Havu VK, Nurmi M, Rinne A (1995) Expression of acid cysteine proteinase inhibitor (ACPI) in the normal prostate, benign prostatic hyperplasia and adenocarcinoma. Int. J. Cancer 62: 1-4.
35. Stonelake PS, Jones CE, Neoptolemos JP, Baker PR (1997) Proteinase inhibitors reduce basement membrane degradation by human breast cancer cell lines. Brit. J. Cancer 75: 951-959.
36. Ulbricht B, Hagmann W, Ebert W, Spiess E (1996) Differential secretion of cathepsins B and L from normal and tumor human lung cells stimulated by 12(S)-hydroxy-eicosatetraenoic acid. Exp. Cell Res. 226: 255-263.
37. Ways DK, Kukoly CA, de Vente J, Hooker HL, Bryant WO, Posekany KJ, Fletcher DJ, Cook PP, Parker PJ (1995) MCF-7 breast cancer cells transfected with protein kinase C-α exhibit altered expression of the other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J. Clin. Invest. 95: 1906-1915.
38. Waghray A, Keppler D, Sloane BF, Schuger L, Chen YQ (2002) Analysis of a truncated form of cathepsin H in human prostate tumor cells. J. Biol. Chem. 277: 11533-11538.
39. Webber M, Bello D, Quader S (1996) Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Prostate 29: 386-394.
40. Wolters PJ, Chapman HA (2000) Importance of lysosomal cysteine proteases in lung disease. Respir. Res. 1: 170-177.